Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) dropped 4.7% during trading on Monday . The stock traded as low as $20.43 and last traded at $20.73. Approximately 262,616 shares were traded during mid-day trading, a decline of 77% from the average daily volume of 1,133,167 shares. The stock had previously closed at $21.76. Analyst […]
Frazier Life Sciences Management L.P. bought a new position in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 69,406 shares of the biopharmaceutical company’s stock, valued at approximately $16,059,000. Frazier Life Sciences […]
Avidity Partners Management LP decreased its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 11.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 710,000 shares of the biopharmaceutical company’s stock after selling 91,100 shares during the period. Intra-Cellular Therapies accounts for about […]
Avidity Partners Management LP decreased its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 11.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 710,000 shares of the biopharmaceutical company’s stock after selling 91,100 shares during the period. Intra-Cellular Therapies accounts for about […]
Avidity Partners Management LP cut its stake in argenx SE (NASDAQ:ARGX – Free Report) by 61.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 31,000 shares of the company’s stock after selling 49,600 shares during the quarter. Avidity Partners […]